We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Bristol-Myers Squibb Enters into Agreement with Five Prime Therapeutics

News   Oct 24, 2015

 
Bristol-Myers Squibb Enters into Agreement with Five Prime Therapeutics
 
 
 

RELATED ARTICLES

T Cell Study Uncovers New Hurdle for Developing Immunotherapies

News

There's an unexpected challenge to be overcome - T cell receptors can be more cross-reactive than previously thought.

READ MORE

Obesity & Vitamin D Deficiency May Indicate Greater Breast Cancer Risk

News

New study demonstrates that postmenopausal women have an increased risk of vitamin D deficiency at the time of breast cancer diagnosis, associated with a higher rate of obesity.

READ MORE

Experimental Nasal Influenza Vaccine Tested in Kids, Teens

News

NIH-supported Phase 1 trial of potential broadly protective vaccine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE